Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.96M Buy
3,754
+12
+0.3% +$16.4K 2.54% 14
2025
Q4
$4M Sell
3,742
-11
-0.3% -$11.5K 1.74% 24
2025
Q3
$3.63M Sell
3,753
-6
-0.2% -$4.72K 1.6% 24
2025
Q2
$3.01M Buy
3,759
+1,230
+49% +$883K 1.32% 28
2025
Q1
$1.68M Buy
2,529
+20
+0.8% +$14.6K 0.83% 35
2024
Q4
$1.74M Buy
2,509
+39
+2% +$28K 0.83% 33
2024
Q3
$2.06M Sell
2,470
-496
-17% -$443K 0.97% 28
2024
Q2
$3.03M Buy
2,966
+72
+2% +$69.2K 1.29% 28
2024
Q1
$2.81M Buy
2,894
+504
+21% +$447K 1.24% 27
2023
Q4
$1.81M Buy
2,390
+110
+5% +$72.6K 0.9% 32
2023
Q3
$1.34M Buy
2,280
+212
+10% +$141K 0.89% 32
2023
Q2
$1.5M Buy
+2,068
New +$1.41M 0.94% 30

Other funds holding ASML

Scholtz & Company's ASML Position: Q1 2026 in Review

Scholtz & Company increased its ASML (ASML) stake by 0.32% in Q1 2026, buying an estimated $16.4K and bringing the position to 3,754 shares worth $4.96M. The position accounts for 2.54% of the portfolio, ranked #14.

Scholtz & Company first reported a position in ASML in Q2 2023 and has held it in 12 quarters since. 2,188 funds tracked by Wall St. Rank hold ASML as of Q1 2026.

  • Scholtz & Company held 3,754 shares of ASML worth $4.96M as of Q1 2026.
  • Scholtz & Company bought 12 ASML shares in Q1 2026, an estimated $16.4K.
  • ASML made up 2.54% of Scholtz & Company's portfolio in Q1 2026, its #14 holding.
  • Scholtz & Company first reported a position in ASML in Q2 2023 and has held it in 12 quarters since.
  • 2,188 funds tracked by Wall St. Rank held ASML as of Q1 2026.

Based on Scholtz & Company's 13F filing for Q1 2026, filed 15 May 2026.